Sterling Capital Management LLC Novo Cure LTD Transaction History
Sterling Capital Management LLC
- $7.3 Trillion
- Q4 2024
A detailed history of Sterling Capital Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Sterling Capital Management LLC holds 107 shares of NVCR stock, worth $2,363. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107
Previous 110
2.73%
Holding current value
$2,363
Previous $1.72 Million
85.51%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$268 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$261 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$196 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$106 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$60.5 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.32B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...